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Background: The National Essential Medicine System (NEMS) is a new policy in China launched in 2009 to improve
the appropriate use of medications. This study aims to examine the outcomes of the NEMS objectives in terms of
the rational use of medicines in primary health care facilities in China.
Methods: A total of 28,651 prescriptions were collected from 146 township health centers in four provinces of
China by means of a field survey conducted in 2010–2011. Indicators of rational drug use were extracted and
compared using a pre/post design and then evaluated with regard to the World Health Organization (WHO)
Standard Guidelines and data from previous research.
Results: The average number of drugs per prescription decreased from 3.64 to 3.46 (p < 0.01) between 2009 and
2010. Little effect was found for the NEMS on the average number of antibiotics per prescription, but the percentage of
prescriptions including antibiotics decreased from 60.26 to 58.48% (p < 0.01). Prescriptions for injections or adrenal
corticosteroids also decreased, to 40.31 and 11.16% of all prescriptions, respectively. All these positive issues were also
recorded in 2011. However, each of the above values remained higher than WHO standards. The percentage of drugs
prescribed from the Essential Drug List increased after the implementation of the NEMS (p < 0.01). Where the available
data allowed changes in costs to be assessed, the average expense per prescription increased significantly, from 25.77
to 27.09 yuan (p < 0.01).
Conclusions: The NEMS effectively improved rational medicine use in China. However, polypharmacy and the over-
prescription of antibiotics and injections remain common. There is still a large unfinished agenda requiring policy
improvements. Treatment guidelines, intensive support supervision, and continuing training for both professionals
and consumers are the essential actions that need to be taken.
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Rational drug use (RDU) requires that patients receive
medications appropriate to their clinical needs, in doses
that meet their own individual requirements, for an ad-
equate period of time, and at the lowest cost to them and
their community [1]. However, all countries, both rich and
poor, have encountered problems with the insufficient use* Correspondence: bianying@umac.mo
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unless otherwise stated.of beneficial, cost-effective drugs and the over use of
unnecessary drugs. According to a World Health
Organization (WHO) report, more than 50% of all medi-
cines were prescribed, dispensed, or sold inappropriately
worldwide, and 50% of patients failed to take their medi-
cines correctly [2]. The medically inappropriate and eco-
nomically inefficient use of drugs also occurs frequently in
China. The consumption of intravenous fluids was esti-
mated at eight bottles per person in China in 2009, a
figure much higher than the overall global level (2.5–3.3
bottles). The overuse of antibiotics is another commontd. This is an Open Access article distributed under the terms of the Creative
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heaviest users of antibiotics, with 70% of prescriptions
containing antibiotics [3].
In China, hospitals can charge 15% over the wholesale
price for drugs. This drug mark-up was initially intro-
duced to compensate facilities for providing services below
cost, as stipulated in the required fee schedule set by the
government. However, this compensatory practice induced
serious health hazards and encouraged physicians to
over-prescribe unnecessary medicines, especially those
that were more expensive or profitable. In 2009, the cost
of drugs in China was 766 billion yuan, accounting for
41% of the total medical cost, and the cost of drugs per
capita was 574 yuan [4]. The irrational use of medicines
has resulted in not only a waste of resources but also
adverse drug reactions (ADRs), drug resistance and in-
creased drug-related morbidity and mortality [5]. It was
estimated that about 2.5 million patients each year were
admitted to the hospital owing to serious ADRs, and
60% of cases of acquired deafness in children were caused
by irrational use of ototoxic drugs [6].
In 2009, increasing concerns regarding the appropriate-
ness of medicinal drug use and access to safe and effective
essential medicines led the Chinese government to intro-
duce the National Essential Medicine System (NEMS) for
public primary health care facilities, with the intention of
extending it to private providers and hospitals. This pro-
gram was a new policy in China and advocated prioritizing
the use of essential medicines and the rational use of essen-
tial medicines. The program’s key objectives included re-
moving the profit link between health institutions, doctors,
and medicines and the improvement of medicine use.
The core of the program was the Essential Drug List (EDL),
which included selected low-cost medicines for common
treatable diseases affecting vast numbers of people. The
list for primary health care facilities contained 307 generic
medicines (205 Western medicines and 102 traditional
Chinese medicines). All public primary health care set-
tings were required to stock and prescribe only drugs
from the EDL and to sell them at cost (zero-profit drug
policy). Clinical treatment guidelines and formulas for
the administration of essential medicines were developed
to regulate the behavior of health workers. Local social
health insurance programs (including the New Rural
Cooperative Medical Scheme) covered all essential medi-
cines and provided a higher reimbursement for listed drugs
than for non-listed drugs. However, different provinces var-
ied in terms of the reimbursement rate.
To date, the initial three-year implementation plan has
been realized. Clearly, there is a need to investigate the
outcomes of the NEMS objectives with the further aim
of contributing to the continued improvement of the
system. Consequently, the purpose of this study was to
examine the outcomes resulting from NEMS in terms ofrational drug use in primary health care facilities and to




This was an ex post facto comparative study. Indicators of
RDU in rural township health centers (THCs), a primary
health care level in China, were compared before and after
the implementation of the NEMS, and discussed with
regard to WHO Standard Guidelines and data from other
researches. Four provinces (Shandong, Zhejiang, Anhui,
and Ningxia) representing contexts with varying levels
of socioeconomic status (SES) were purposively selected
as research areas. Shandong and Zhejiang are located in
Eastern China and represent the developed parts of China.
Anhui is part of the central region of China and an ex-
ample of a moderately developed region. Ningxia is in the
northwest part of China and is an undeveloped region.
The New Rural Cooperative Medical Scheme covered over
95% of the rural population in each of the selected prov-
inces until 2011 [7].
The survey in Zhejiang and Anhui was conducted in
2010. It was designed to reflect changes in the rational use
of medicine between 2009 and 2010. Quota sampling was
used to select two cities in each selected province (one with
high SES and one with low SES). From each of the four
selected cities, three counties were randomly chosen. All
public THCs in the 12 chosen counties were investigated,
resulting in a total of 113 THCs. In each THC, outpatient
prescriptions from August 21 to August 30 in 2009 and
2010 were collected, and 200 prescriptions were selected
using systematic random sampling (ten prescriptions per
day). Generally, each consultation resulted in one prescrip-
tion for drugs, treatments, or other recommendations.
The survey in Shandong and Ningxia was conducted
in 2011. It was designed to reflect changes in the rational
use of medicine during 2009–2011. A county of medium
size and middle development level in Shandong was se-
lected for sampling. All 17 THCs in this county were in-
vestigated. In Ningxia, 16 THCs were selected with quota
sampling, drawing upon divisions previously made by local
officials dividing the province into low, middle, and high
SES levels. One county was randomly selected from each
of the three SES strata. The counties selected were Xiji,
Tongxin and Qingtongxia. Based on size of the selected
county, eight THCs were randomly selected from Xiji, and
four were randomly chosen from each of the other two
selected counties. In each THC, outpatient prescriptions
issued between January 1 and June 30 in 2009, 2010, and
2011 were collected, and a sample of 180 prescriptions
was drawn using systematic random sampling (at least ten
prescriptions per month). The sampling method is differ-
ent in the two surveys. During the first stage of research,
Song et al. BMC Health Services Research 2014, 14:507 Page 3 of 7
http://www.biomedcentral.com/1472-6963/14/507in Zhejiang and Anhui, we encountered a few unexpected
problems in carrying out the sampling plan. Based on this
experience, we made some adjustments in the sampling in
Shandong and Ningxia.
All parts of the present study were approved by the eth-
ics committee of Institute of Chinese Medical Sciences at
the University of Macau. Data collection was anonymous
(name or identifying information of the patients, general
practitioners, and pharmacists were not obtained). The
final data available for analysis in this study consist of
28,651 prescriptions, described in Table 1.Indicators
Drug use indicators for primary health care facilities from
the WHO/International Network for the Rational Use of
Drugs have a central place in assessing drug use practices,
as they have been shown to be both feasibly measured and
informative as first level indicators [8,9]. The final versions
of the pretested indicators in this study were derived by
taking these indicators as a reference and combining them
with information about the specific situation in China. Six
indicators were pretested in this study:
1. Average number of drugs per prescription (ANDPP)
2. Percentage of drugs prescribed from the EDL (PED)
3. Average number of antibiotics per prescription
(ANAPP)
4. Percentage of prescriptions including an antibiotic
(PPA)
5. Percentage of prescriptions including an injection
(PPI)
6. Percentage of prescriptions including adrenal
corticosteroid (PPC)Data analysis
We extracted the data from each prescription, including
number of medicines, number of essential medicines, num-
ber of antibiotics, use of injections, and use of adrenal corti-
costeroids. In Shandong and Ningxia, the total medical cost
per prescription was also accessible. The drug use indi-
cators were computed as follows:Table 1 Numbers of township health centers and
prescriptions selected in four Chinese provinces
THCs Prescriptions
2009 2010 2011
Anhui 26 2575 2570 0
Zhejiang 87 8408 8700 0
Shandong 17 1046 1009 982
Ningxia 16 1033 1219 1109
Total 146 13062 13498 2091
Note: THCs = township health centers.ANDPP ¼ total number of drugs prescribed
total number of prescriptions surveyed
PED ¼ total number of essential medicines prescribed  100%
total number of drugs prescribed
ANAPP ¼ total number of antibiotics prescribed
total number of prescriptions surveyed
PPA ¼ number of prescripitons including an antibiotic  100%
total number of prescriptions surveyed
PPI ¼ number of prescriptions including an injection  100%
total number of prescriptions surveyed
PPC ¼ number of prescriptions including adrenal corticosteroid  100%
total number of prescriptions surveyed
Data analyses were performed with IBM SPSS Statistics
Version 19.0 (Armonk, New York, USA). The 2009 data
were considered to be in the pre-reform period, and the
2010 and 2011 data were considered to be in the post-
reform period. Descriptive analyses of variables were
carried out on the basis of means and corresponding
percentages. Student’s t-test was performed to compare
the means, and Fisher’s exact test was used to compare
the percentage distributions between the two periods.
Additionally, during the analysis, the consumer price index
was used to correct the total medical cost per prescription
for inflation or deflation between the survey year and the
base year (2009), and the values of this variable were trans-
formed into natural logarithms of the observed value to
address the positive skew of the expenditure data.
Results
General situation
Table 2 shows the indicators and corresponding changes
in the use of essential medicines, antibiotics, injections,
and adrenal corticosteroids for outpatient visits in 146 fa-
cilities from the four selected provinces between 2009 and
2010.
The mean number of drugs prescribed per prescription
decreased from 3.64 to 3.46 between 2009 and 2010. Sig-
nificantly fewer drugs were prescribed per prescription after
the NEMS (p < 0.01). In 2010, 15.06% of outpatient pre-
scriptions included one drug, 23.02% included two drugs,
20.98% included three drugs, and 40.91% included four
or more (Table 3). The prescriptions where four or more
drugs were prescribed decreased compared with 2009
(p < 0.05).
Moreover, overall, 79.89% of drugs prescribed were from
the EDL in 2010, compared with 63.33% in 2009. Of all
outpatient prescriptions in 2009, 60.26% included one or
more antibiotics. This percentage decreased to 58.48%
in 2010 (p < 0.01). The mean number of antibiotics per
prescription was 0.8 in 2010, almost equal to the mean
of 0.81 in 2009. However, the number of antibiotics per
Table 2 Drug use indicators at 146 township health centers in four Chinese provinces, 2009–2010
Anhui Zhejiang Shandong Ningxia Total
2009 2010 2009 2010 2009 2010 2009 2010 2009 2010
ANDPP 4.17 4.25 ↑ 3.57 3.3 ↓* 3.37 3.28 ↓ 3.23 3.12 ↓ 3.64 3.46 ↓*
PED, % 75.62 86.88 ↑* 61.31 83.29 ↑* 50.65 49.41 ↓ 55.35 60.59 ↑ 63.33 79.89 ↑*
ANAPP 0.96 1 ↑ 0.79 0.75 ↓* 0.73 0.71 ↓* 0.72 0.81 ↑* 0.81 0.8 ↓
PPA, % 67.81 70.35 ↑* 59.92 55.52 ↓* 51.43 51.54 ↑ 53.15 60.38 ↑* 60.26 58.48 ↓*
PPI, % 51.11 50.43 ↓ 43.74 40.35 ↓* 30.59 29.04 ↓ 28.36 27.97 ↓ 42.93 40.31 ↓*
PPC, % 22.68 22.10 ↓ 11.91 9.22 ↓* 11.09 10.70 ↓ 1.65 2.30 ↑ 13.15 11.16 ↓*
Note: ↑ = 2010 − 2009 > 0; ↓ = 2010 − 2009 < 0.
ANDPP = average number of drugs per prescription; PED = percentage of drugs prescribed from the Essential Drug List; ANAPP = average number of antibiotics
per prescription; PPA = percentage of prescriptions including an antibiotic; PPI = percentage of prescriptions including an injection; PPC = percentage of
prescriptions including adrenal corticosteroid.
*= p < 0.05, p-value refers to t-test to compare means or exact test to compare proportion distributions between the two periods.
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absence of an overall reduction was entirely because of
more antibiotics per prescription in Anhui and Ningxia.
Additionally, in 2009, 2.08% of all prescriptions contained
three or more antibiotics; this proportion increased to
2.26% in 2010 (p < 0.05) (see Table 4).
The rates of prescriptions containing injections de-
creased in all selected provinces between 2009 and 2010.
On average, 40.31% of consultations resulted in an injec-
tion in 2010. The use of adrenal corticosteroids was also
improved significantly. The percentage of prescriptions that
included adrenal corticosteroids decreased to 11.16% in
2010.
Further investigation in Shandong and Ningxia
The situation of rational drug use in 2011 was further in-
vestigated in Shandong and Ningxia. As is shown in Table 5,
results of this additional investigation revealed that the rate
of medicines prescribed from the EDL increased each year
after the implementation of the NEMS (p < 0.01). There
were significantly fewer prescriptions with an antibiotic in
2011, and the average number of antibiotics per prescrip-




Prescriptions, N (%)Δ RD (95% CI)
2009 2010
0 2 (0.02) 4 (0.03) +0.01 (−0.02, +0.05)
1 1745 (13.36) 2036 (15.06) +1.70 (+0.87, +2.54)
2 2653 (20.31) 3111 (23.02) +2.71 (+1.72, +3.70)
3 2657 (20.34) 2836 (20.98) +0.64 (−0.33, +1.61)
4 2028 (15.53) 1847 (13.67) −1.86 (−2.71, −1.01)
5 1796 (13.75) 1660 (12.28) −1.47 (−2.28, −0.66)
≥ 6 2181 (16.70) 2022 (14.96) −1.74 (−2.62, −0.86)
Note: RD = the difference of proportion between the years; CI=confidence
interval.
Δ= There is statistically significant difference (p < 0.05) in proportion
distributions of prescriptions by number of drugs between 2009 and 2010.analysis indicated that fewer outpatient prescriptions in-
cluded injections (p < 0.01). Frequently-prescribed injections
(excluding traditional Chinese medicine injections) included
solutions correcting water, electrolyte, and acid–base distur-
bances (35.21%); antibiotics (23.12%); vitamins and minerals
(9.66%); antiviral medicines (7.33%); and adrenal corticoste-
roids (5.08%). However, the available data do not dem-
onstrate a clear improvement in ANDPP or PPC in 2011,
compared with 2009.
The total medical cost per prescription significantly in-
creased between 2009 and 2011, from 25.77 to 27.09 yuan
(p < 0.01). Furthermore, the cost of prescriptions contain-
ing antibiotics were higher than the cost of those without
antibiotics (p < 0.01). Similarly, the cost of prescriptions
where an injection was prescribed was significantly higher
than that where no injection was prescribed (p < 0.01).Discussion
The township health center plays an important role in
providing primary health care services to the large popu-
lation in rural China. The findings of this study may provide
quantitative baseline data for monitoring and improving
prescribing processes and rational drug use in China.Table 4 Prescriptions by number of antibiotics per
prescription, 2009 and 2010
No. of antibiotics
per prescription
Prescriptions, N (%)Δ RD (95% CI)
2009 2010
No antibiotics 5191(39.74) 5612(41.52) +1.78 (+0.60, +2.96)
With antibiotics 7871(60.26) 7904(58.48) −1.78 (−2.96, −0.60)
1 5450(41.72) 5403(39.97) −1.75 (−3.28, −0.22)
2 2149(16.45) 2195(16.24) −0.21 (−1.36, +0.94)
≥3 272(2.08) 306(2.26) +0.18 (−0.27, +0.63)
Note: RD = the difference of proportion between the years; CI=confidence
interval.
Δ= There is statistically significant difference (p < 0.05) in proportion
distributions of prescriptions by number of antibiotics between 2009 and
2010.
Table 5 Drug use indicators at 33 township health
centers in Shandong and Ningxia, China, 2009–2011
Shandong Ningxia Total
2009 2010 2011 2009 2010 2011 2009 2010 2011
ANDPP 3.37 3.28 3.36 3.23 3.12 3.15 3.30 3.19 3.25
PED, % 50.65 49.41 65.67 55.35 60.59 70.64 53.03 55.49 68.31
ANAPP 0.73 0.71 0.66 0.72 0.81 0.70 0.73 0.77 0.68
PPA, % 51.43 51.54 47.15 53.15 60.38 54.19 52.28 56.37 50.88
PPI, % 30.59 29.04 26.68 28.36 27.97 22.36 29.50 28.50 24.40
PPC, % 11.09 10.70 11.20 1.65 2.30 1.89 6.40 6.10 6.30
Note: ANDPP = average number of drugs per prescription; PED = percentage
of drugs prescribed from the Essential Drug List; ANAPP = average number of
antibiotics per prescription; PPA = percentage of prescriptions including an
antibiotic; PPI = percentage of prescriptions including an injection;
PPC = percentage of prescriptions including adrenal corticosteroid.
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were prescribed per prescription after China’s implemen-
tation of the NEMS (p < 0.01). In 2010, patients were pre-
scribed an average of 3.46 drugs per prescription, which
was however still double the derived WHO standard value
of 1.6–1.8 [10]. It was also higher than the average of 2.2
drugs prescribed per patient visit found in a study of 17
developing countries, where the highest national average
was 3.8, found in Indonesia and Nigeria [11]. Thus, our
study indicates that the trend towards polypharmacy per-
sisting in China was among the world’s most severe cases.
Furthermore, we found that about 27.24% prescriptions
contained five or more different kinds of drugs in 2010;
the highest number was 32 drugs for a single prescription.
Multi-drug use may increase the risk of undesirable drug
interactions and needs more attention.
Following the implementation of the NEMS, all THCs
were required to stock and prescribe drugs solely from the
EDL and to sell them at cost, a policy aimed at ending the
interest link between physicians and drugs and reducing
incentives for health care providers to over-prescribe. The
current trend towards polypharmacy may be attributed to
patients’ demands; patients believe that prescribing more
drugs will ensure improvement and facilitate the cure of
their conditions more quickly [12]. Another contributing
factor could be that the treatment is based purely on
symptoms instead of a full diagnosis. Though clinical
treatment guidelines and formulas for essential medicines
have been developed, they have not yet been fully accepted
or followed by physicians in THCs. Another possible fac-
tor could be that “bargain mentality” encourages irrational
use. For example, in Ningxia, there is an annual medical
compensation for outpatient services (about 30 yuan per
person). Patients prefer to get medicines for free and
always pressure prescribers to prescribe medicines within
the quota, especially at the end of the fiscal year, regardless
of whether they need these drugs or not. Thus, RDUeducation for both health care providers and consumers
should be further promoted.
Second, analysis of the data revealed that essential medi-
cines constitute a reasonably high proportion of all medi-
cines prescribed in THCs after the implementation of the
NEMS. On average, 80% of the drugs prescribed appeared
on the EDL in 2010. The priority use of essential medi-
cines is worth advocating. However, doctors in primary
health care facilities should not be limited to prescribing
only essential medicines and should have some scope for
autonomy within a certain range. It is rare for a country to
reduce medicine costs and promote rational medication
by controlling the prescription practices of doctors with
an EDL covering a few medicine categories. This rarity is
because of the specificity of the medical industry and the
individual variations within it across contexts [13].
Third, our study showed that the number of prescriptions
where one or more antibiotics were prescribed decreased
to 58.48% in 2010 (p < 0.01), whereas the WHO rec-
ommendation is 20.0–26.8% [8]. Moreover, the propor-
tion containing more antibiotics increased somewhat,
and the mean number of antibiotics per prescription has
not changed. Antibiotics are essential, but their overuse
can increase antibiotic resistance, which will endanger their
therapeutic effectiveness, increase treatment failure, and, as
a result, lead to longer and more severe illness episodes as-
sociated with higher costs and an increased mortality rate
[14]. The major factors reported to influence the high per-
centage of antibiotics prescribed elsewhere are physicians’
lack of knowledge about appropriate antibiotic use, includ-
ing the overestimation of the severity of the illness to
justify prescribing an antibiotic, and pressure from pa-
tients who believe that antibiotics provide rapid symp-
tomatic relief from disease [15,16]. The same factors may
play a role in China. Hence, follow-up research should focus
on the improvement of the use and management of antibi-
otics. There is also an urgent need for public education.
Fourth, our results showed that the use of injections and
adrenal corticosteroids improved significantly after the im-
plementation of the NEMS. However, the overall percent-
age of prescriptions containing injections in Shandong and
Ningxia in 2011 was 24.4%, still higher than the percentage
reported previously in 35 developing countries (22.8%)
[17]. In China, the mistaken belief that “Injections mean
you will get well sooner” has always caused patients to re-
quest injections [18]. Compared with oral drug therapy, in-
jections are more expensive because of the additional cost
of syringes, sterilization control, and well-trained personnel.
In addition to increasing the economic burden of patients,
overuse of injections brings risks of unsafe needles that can
increase the transmission of AIDS, hepatitis B and C, and
other blood-borne diseases [19]. Most notably in our sur-
vey, 23.12% of injections prescribed were antibiotics, poten-
tially increasing the risk of antibiotic resistance.
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vealed that the total medical cost per prescription signifi-
cantly increased between 2009 and 2011. With the price
control policy of the NEMS, medicine prices in 2011 were
reduced by 25% from 2009 prices [20]. However, medical
costs did not fall correspondingly. The poor outcome
might be partly caused by patients being treated with too
many medicines, especially antibiotics. The results con-
firmed that the medical cost per prescription was higher
with antibiotics or injections than that without, a finding
that is consistent with other research [21]. Furthermore, a
report from three Chinese provinces previously revealed
that certain manufacturers ceased production of some
essential drugs because the price controls and recom-
mended procurement procedures in the NEMS severely
curtailed their profits. The report also revealed that many
health care providers complained that the prices they were
paying for some drugs under the NEMS were higher than
those they had paid before the NEMS was introduced in
their facility [22]. These factors could be a contributor to
rising medical costs. Additionally, the financial incentives
that manufacturers provide to hospitals and doctors might
also lead to the frequent use of medicines with higher
prices due to the persistence of widespread corruption
in the procurement process [23-25]. Where profits from
selling drugs have been eliminated, appropriate financial
compensation mechanisms are needed to ensure the sus-
tainable development of the primary health care facilities,
because drug revenue previously accounted for more than
50% of hospital revenue in China [26].
The results of this study should be interpreted in light
of several limitations. First, China’s NEMS has recently
been launched, and we collected post-implementation in-
formation soon after the introduction. Its effectiveness and
impacts have not been fully realized, and there is limited
empirical evidence to draw upon in making conclusions
about its efficacy. Second, the results of this study were
based only on four selected provinces. Although these
four provinces were selected purposively to explore dif-
ferent development levels, the conclusions of this study
should be generalized to the whole of China only with
caution. Third, the prescription analysis conducted in this
study only examined outpatient prescriptions and excluded
inpatient prescriptions mainly owing to limited data
availability.
Conclusions
In conclusion, most of the observed indicators in 2010
and 2011 have improved compared with 2009. There was
a positive association between the NEMS and the more
appropriate use of medications in primary health care
settings in China. However, polypharmacy and the over-
prescription of antibiotics and injections remain common.
At the time of our data collection, the RDU indicators hadnot yet met the WHO Standard Guidelines. The NEMS
agenda remains largely unfinished, and its realization
requires further policy improvements. In light of this need
for future improvements, we provide some recommenda-
tions based on the above findings and discussion. First,
treatment guidelines should be highlighted and closely
followed. Health delivery systems should routinely assess
medicine use to encourage rational prescription. Next, the
concept of rational drug use should be incorporated into
the basic and continuing education of health care pro-
viders. Finally, it is necessary to improve training on RDU
for consumers to gradually change their mistaken beliefs
and thus reduce their demand for drugs that do not bring
additional health benefits.
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